Key Laboratory of Medical Molecule Science and Pharmaceutical Engineering, Ministry of Industry and Information Technology, Institute of Biochemical Engineering, School of Chemistry and Chemical Engineering, Beijing Institute of Technology, Beijing 100081, China.
Key Laboratory for Industrial Biocatalysis, Ministry of Education, Department of Chemical Engineering, Tsinghua University, Beijing 100084, China.
ACS Synth Biol. 2024 Apr 19;13(4):1059-1076. doi: 10.1021/acssynbio.4c00061. Epub 2024 Mar 28.
Triterpenoids possess a range of biological activities and are extensively utilized in the pharmaceutical, food, cosmetic, and chemical industries. Traditionally, they are acquired through chemical synthesis and plant extraction. However, these methods have drawbacks, including high energy consumption, environmental pollution, and being time-consuming. Recently, the de novo synthesis of triterpenoids in microbial cell factories has been achieved. This represents a promising and environmentally friendly alternative to traditional supply methods. , known for its robustness, safety, and ample precursor supply, stands out as an ideal candidate for triterpenoid biosynthesis. However, challenges persist in industrial production and economic feasibility of triterpenoid biosynthesis. Consequently, metabolic engineering approaches have been applied to improve the triterpenoid yield, leading to substantial progress. This review explores triterpenoids biosynthesis mechanisms in and strategies for efficient production. Finally, the review also discusses current challenges and proposes potential solutions, offering insights for future engineering.
三萜类化合物具有广泛的生物活性,广泛应用于制药、食品、化妆品和化学工业。传统上,它们是通过化学合成和植物提取获得的。然而,这些方法存在一些缺点,包括高能耗、环境污染和耗时。最近,在微生物细胞工厂中实现了三萜类化合物的从头合成。这是一种有前途的、环保的替代传统供应方法。因其稳健性、安全性和丰富的前体供应而脱颖而出,是三萜类化合物生物合成的理想候选物。然而,三萜类化合物生物合成的工业生产和经济可行性仍然存在挑战。因此,已经应用代谢工程方法来提高三萜类化合物的产量,取得了重大进展。本文探讨了在 中三萜类化合物的生物合成机制和提高产量的策略。最后,本文还讨论了当前的挑战并提出了潜在的解决方案,为未来的工程提供了思路。